FOCUS ON INCRETIN-BASED THERAPIES FOR PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE

被引：0
作者：
Garber, Alan J. [1 ,2 ,3 ,4 ]
机构：
[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Mol Biol, Houston, TX 77030 USA
来源：
ENDOCRINE PRACTICE | 2011年 / 17卷
关键词：
ALL-CAUSE MORTALITY; GLYCEMIC CONTROL; POOLED ANALYSIS; MICROVASCULAR COMPLICATIONS; SEVERE HYPOGLYCEMIA; PEPTIDE-1; ANALOG; EXENATIDE TWICE; GLUCOSE CONTROL; GLP-1; RISK-FACTORS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13 / 19
页数：7
相关论文
共 78 条
[1]   Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study [J].
Adler, AI ;
Stratton, IM ;
Neil, HAW ;
Yudkin, JS ;
Matthews, DR ;
Cull, CA ;
Wright, AD ;
Turner, RC ;
Holman, RR .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :412-419
[2]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[3]  
Amylin Pharmaceuticals Inc Eli Lilly and Company Alkermes Inc, EX TQT SHOW NO PROL
[4]  
[Anonymous], VICT LIR PACK INS
[5]  
[Anonymous], JAN SIT PACK INS
[6]  
[Anonymous], 2011, DIABETES S1, V60, P296
[7]  
[Anonymous], 2011, TRADJ LIN PACK INS
[8]  
[Anonymous], 2011, National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States
[9]  
[Anonymous], GLUC METF PACK INS
[10]  
[Anonymous], 2011, ONGL SAX PACK INS
12345678